Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Geneva Foundation for Medical Education and Research
Euro Pub
ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Association of glycated hemoglobin and body mass index with chronic kidney disease among type 2 diabetic patients in North-eastern Thailand
International Conference on Gastrointestinal Cancer and Therapeutics & 4th World Congress on Digestive & Metabolic Diseases & 26th Annual Congress on Cancer Science and Targeted Therapies
Sojib Bin Zaman
Charity University Medicine Berlin, GermanyKhon Kae University, Thailand
Background: The prevalence of chronic kidney disease (CKD) amidst Thai adult type 2 diabetes mellitus (T2DM) patients is quite
high. Uncontrolled DM and obesity can play a role to initiate this renal vascular complication. Glycated hemoglobin (HbA1c) a wellknown
valid biomarker to estimate glycemic control. However, it is not clear whether HbA1c and body mass index (BMI) with other
conventional indicators can act as a reliable determinant to predict CKD.
Methods: A diabetic registry was used to collect 4042 participants from a large district hospital in the Northeast of Thailand. CKD
was reported as estimated glomerular filtration rate; eGFR<60 ml/min/1.73m2. Using STATA, multiple logistic regression analysis
was performed to report adjusted odds ratio.
Results: More than one-fifth of T2DM patients (887, 21.9%), were found with CKD. The majority of the participants were in the poor
glycemic state (82%), and 43% of them were overweight. HbA1c was found not to be a reliable indicator for CKD. Age, hypertension,
microalbuminuria, and triglyceride were considered to be the implied risk factors besides HbA1c in this study. Also, BMI is seemed
to decrease in the course of developing CKD.
Conclusion: It appears to the presence or lack of generally accepted indicators for detecting CKD in T2DM patients. The lower values
of HbA1c and BMI for high-risk CKD patients might be explained by the fact that CKD patients usually develop anemia and their
nutritional status can declines. Both the contemporary guidelines of HbA1c and BMI need to be modified in consideration of CKD
patients.